A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/17 (2006.01) A61P 3/04 (2006.01) A61K 9/00 (2006.01)
Patent
CA 2555826
Pharmaceutical compositions and methods are described comprising at lease one Y2 receptor-binding peptide, such as peptide YY (PYY), Neuropeptide Y (NPY) or Pancreatic Peptide (PP) and one or more mucosal delivery-enhancing agents for enhanced nasal mucosal delivery of the peptide YY, for treating a variety of diseases and conditions in mammalian subjects, including obesity.
La présente invention concerne des procédés et des compositions pharmaceutiques comprenant au moins un peptide se liant au récepteur Y2. Il s'agit notamment du Peptide YY (PYY), du Neuropeptide Y (NPY), ou du Peptide Pancréatique (PP). Il est accompagné d'au moins un agent renforçant l'apport aux muqueuses, de façon à renforcer l'apport aux muqueuses nasales du peptide YY. Cela permet de traiter diverses maladies et états affectant les mammifères, et notamment l'obésité.
Brandt Gordon
Kleppe Mary S.
Macevilly Conor J.
Quay Steven C.
Borden Ladner Gervais Llp
Mdrna Inc.
Nastech Pharmaceutical Company Inc.
LandOfFree
Compositions and methods for enhanced mucosal delivery of y2... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for enhanced mucosal delivery of y2..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for enhanced mucosal delivery of y2... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1503666